Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia

Published:2004-01 Issue:1 Volume:43 Page:7-16
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Laskin Janessa J,Erridge Sara C,Coldman Andrew J,D’yachkova Yulia,Speers Caroline,Westeel Virginie,Hislop T.Greg,Olivotto Ivo A,Murray Nevin

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom;Sambrook;Br. J. Cancer,2001

2. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group;Richardson;Med. J. Aust.,2000

3. Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study;Palmer;Radiother. Oncol.,1990

4. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent;Pujol;Br. J. Cancer,2000

5. A meta-analysis of thoracic radiotherapy for small-cell lung cancer;Pignon;N. Engl. J. Med.,1992

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada;Frontiers in Oncology;2023-12-06

2. eIF3a R803K mutation mediates chemotherapy resistance by inducing cellular senescence in small cell lung cancer;Pharmacological Research;2021-12

3. A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer;British Journal of Cancer;2020-11-16

4. Surgical outcomes of early-stage small-cell lung cancer: single-center experience;Asian Cardiovascular and Thoracic Annals;2019-01-19

5. Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer;Journal of Oncology Practice;2016-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3